Case number 1:21-cv-00035
Intercept Pharmaceuticals, Inc. et al v. Dr. Reddy's Laboratories, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2021 | 24 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Apotex Corp., Apotex Inc..(Ormerod, Eve) |
| Jul 6, 2021 | 23 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Defendants' First Set of Requests for the Production of Documents and Things to Plaintiffs Intercept Pharmaceuticals, Inc. and Intercept Pharma Europe Ltd. (Nos. 1-55); and 2) Defendants' First Set of Joint Interrogatories (Nos. 1-6) filed by Apotex Corp., Apotex Inc..(Ormerod, Eve) |
| Mar 12, 2021 | 22 | SO ORDERED (5) Docket Text: SO ORDERED re (40 in 1:20-cv-01214-MN, 32 in 1:20-cv-01155-MN, 36 in 1:20-cv-01215-MN, 34 in 1:20-cv-01154-MN, 21 in 1:21-cv-00035-MN, 38 in 1:20-cv-01105-MN) Stipulation and Order to Consolidate. ALL FUTURE FILINGS SHALL BE MADE IN C.A. NO. 20-1105. Signed by Judge Maryellen Noreika on 3/12/2021. (dlw) |
| Mar 12, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:20-cv-01105-MN. (dlw) |
| Mar 10, 2021 | 21 | Stipulation (5) Docket Text: STIPULATION and Order to Consolidate by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.. (Tigan, Jeremy) |
| Mar 9, 2021 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: Having been advised by the parties of their inability to resolve protective order disputes, IT IS HEREBY ORDERED that a Telephone Conference is set for 4/13/2021 at 12:00 PM before Judge Maryellen Noreika. The opening letter, not to exceed three (3) pages, is due on or before 4/7/2021 and shall attach a copy of the proposed protective order setting forth Plaintiffs' and Defendants' positions. The responsive letter, not to exceed three (3) pages, is due on or before 4/8/2021. Counsel shall provide a dial-in number for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 3/9/2021. (dlw) |
| Mar 3, 2021 | 19 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Feb 26, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (37 in 1:20-cv-01214-MN, 31 in 1:20-cv-01154-MN, 17 in 1:21-cv-00035-MN, 32 in 1:20-cv-01105-MN, 33 in 1:20-cv-01215-MN, 29 in 1:20-cv-01155-MN) STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to March 5, 2021. ORDERED by Judge Maryellen Noreika on 2/26/2021. (dlw) |
| Feb 26, 2021 | 17 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to March 5, 2021 - filed by Apotex Corp., Apotex Inc.. (Ormerod, Eve) |
| Feb 26, 2021 | 18 | Answer to Counterclaim (26) Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Feb 22, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Jovial Wong, Bryce A. Cooper, Alison M. Heydorn for Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, LTD. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Feb 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (35 in 1:20-cv-01214-MN, 27 in 1:20-cv-01155-MN, 30 in 1:20-cv-01105-MN, 31 in 1:20-cv-01215-MN, 29 in 1:20-cv-01154-MN, 15 in 1:21-cv-00035-MN) STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 26, 2021. ORDERED by Judge Maryellen Noreika on 2/19/2021. (dlw) |
| Feb 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [16] MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner, Jovial Wong, Bryce A. Cooper, and Alison M. Heydorn filed by Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, LTD., Dr. Reddy's Laboratories, Inc. ORDERED by Judge Maryellen Noreika on 2/19/2021. (dlw) |
| Feb 19, 2021 | 15 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 26, 2021 - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Feb 19, 2021 | 16 | Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner, Jovial Wong, Bryce A. Cooper, and Alison M. Heydorn - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, LTD.. (Wilson, Samantha) |
| Feb 17, 2021 | 14 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Initial Disclosures Pursuant to Rule 26(A)(1) and 2) Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Disclosures Pursuant to Paragraph 3 of The Default Standard For Discovery filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, LTD..(Wilson, Samantha) |
| Feb 10, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [12] MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy D. Cobb, Douglas A. Behrens, Laura Dolbow, and Mary Swears filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD. ORDERED by Judge Maryellen Noreika on 2/10/2021. (dlw) |
| Feb 10, 2021 | 13 | Notice of Appearance (3) Docket Text: NOTICE of Appearance by Samantha G. Wilson on behalf of Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, LTD. (Wilson, Samantha) |
| Feb 9, 2021 | 12 | Motion for Leave to Appear Pro Hac Vice (10) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy D. Cobb, Douglas A. Behrens, Laura Dolbow, and Mary Swears - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Feb 5, 2021 | 10 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. by Dr. Reddy's Laboratories, LTD., Dr. Reddy's Laboratories, Inc..(Gaza, Anne) |
| Feb 5, 2021 | 11 | Disclosure Statement (4) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dr. Reddy's Laboratories, Ltd. for Dr. Reddy's Laboratories, Inc. filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, LTD.. (Gaza, Anne) |
| Feb 3, 2021 | 9 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Rule 26(A)(1); and (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc..(Blumenfeld, Jack) |
| Jan 27, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD.: For Dr. Reddy's Laboratories, Inc. waiver sent on 1/25/2021, answer due 3/26/2021. (Blumenfeld, Jack) |
| Jan 27, 2021 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD.: For Dr. Reddy's Laboratories, LTD. waiver sent on 1/25/2021, answer due 3/26/2021. (Blumenfeld, Jack) |
| Jan 20, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Jan 14, 2021 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (myr) |
| Jan 13, 2021 | 1 | Main Document (30) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, LTD. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3461795.) - filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD.. (Attachments: # (1) Exhibit A-H, # (2) Civil Cover Sheet)(myr) |
| Jan 13, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (myr) |
| Jan 13, 2021 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE 48,286 ;9,238,673 ;10,047,117 ;10,052,337 ;10,174,073 ;10,751,349 ;10,758,549. (myr) |
| Jan 13, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 12/1/2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/27/2023. (myr) |
| Jan 13, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Jan 13, 2021 | 1 | Civil Cover Sheet (2) |
| Jan 13, 2021 | 1 | Exhibit A-H (631) |
| Jan 13, 2021 | 1 | Complaint* (1) |
